Oxyrane UK
Latest round
- Series D
Last raised
- Nov 2011
Total raised
- $27M
Investors
- 3
About Oxyrane UK
Oxyrane UK is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited diseases. Founded in 2006, the company is headquartered in Manchester, United Kingdom with research facilities in Ghent, Belgium.
Who invested in Oxyrane UK
3 investors across 1 round
See all investors in Oxyrane UK
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Nov 17, 2011
Amount
$27M
Investors
Questions about Oxyrane UK
Who invested in Oxyrane UK?
Oxyrane UK has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oxyrane UK raised?
Oxyrane UK has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oxyrane UK last raise money?
Oxyrane UK's most recent round on record is a Series D, in Nov 2011.
What does Oxyrane UK do?
Oxyrane UK is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited diseases.
Where is Oxyrane UK headquartered?
Oxyrane UK is headquartered in Manchester, UK.
Which VCs invest in companies like Oxyrane UK?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Oxyrane UK's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Oxyrane UK? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.